Novartis won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic version of Novartis' blockbuster heart-failure ...
CEO Narasimhan reportedly downplays Entresto's U.S. patent expiration, projecting strong growth and margin expansion in 2025. Novartis AG NVS shares are trading higher in the premarket session on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback